Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Clin Cancer Res. 2020 Dec 4;27(5):1278–1286. doi: 10.1158/1078-0432.CCR-20-2974

Figure 3. Clinical outcomes of 66 evaluable patients.

Figure 3.

A. Kaplan-Meier survival curves of disease-free survival (DFS) of 66 patients evaluable for efficacy endpoint. B. Kaplan-Meier survival curves of overall survival (OS) of 66 patients evaluable for efficacy endpoint.